1. Health‐Related Quality of Life With Adjuvant Docetaxel‐ and Trastuzumab‐Based Regimens in Patients with Node‐Positive and High‐Risk Node‐Negative, HER2‐Positive Early Breast Cancer: Results from the BCIRG 006 Study. (28th June 2013) Authors: Au, Heather‐Jane; Eiermann, Wolfgang; Robert, Nicholas J.; Pieńkowski, Tadeusz; Crown, John; Martin, Miguel; Pawlicki, Marek; Chan, Arlene; Mackey, John; Glaspy, John; Pintér, Tamás; Liu, Mei‐Ching; Fornander, Tommy; Sehdev, Sandeep; Ferrero, Jean‐Marc; Bée, Valerie; Santana, Maria J.; Miller, Da... Journal: Oncologist Issue: Volume 18:Number 7(2013) Page Start: 812 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗